146 related articles for article (PubMed ID: 20669025)
1. Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease.
Yokota O; Davidson Y; Arai T; Hasegawa M; Akiyama H; Ishizu H; Terada S; Sikkink S; Pickering-Brown S; Mann DM
Acta Neuropathol; 2010 Dec; 120(6):789-801. PubMed ID: 20669025
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
[TBL] [Abstract][Full Text] [Related]
3. Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.
Sorrentino ZA; Goodwin MS; Riffe CJ; Dhillon JS; Xia Y; Gorion KM; Vijayaraghavan N; McFarland KN; Golbe LI; Yachnis AT; Giasson BI
Acta Neuropathol Commun; 2019 Sep; 7(1):142. PubMed ID: 31477175
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355
[TBL] [Abstract][Full Text] [Related]
5. Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
Miller RL; Dhavale DD; O'Shea JY; Andruska KM; Liu J; Franklin EE; Buddhala C; Loftin SK; Cirrito JR; Perrin RJ; Cairns NJ; Campbell MC; Perlmutter JS; Kotzbauer PT
Ann Clin Transl Neurol; 2022 Feb; 9(2):106-121. PubMed ID: 35060360
[TBL] [Abstract][Full Text] [Related]
6. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
7. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
8. The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.
Ferman TJ; Aoki N; Crook JE; Murray ME; Graff-Radford NR; van Gerpen JA; Uitti RJ; Wszolek ZK; Graff-Radford J; Pedraza O; Kantarci K; Boeve BF; Dickson DW
Alzheimers Dement; 2018 Mar; 14(3):330-339. PubMed ID: 29100980
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.
Uchikado H; Lin WL; DeLucia MW; Dickson DW
J Neuropathol Exp Neurol; 2006 Jul; 65(7):685-97. PubMed ID: 16825955
[TBL] [Abstract][Full Text] [Related]
10. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
Cong C; Zhang W; Qian X; Qiu W; Ma C
J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
[TBL] [Abstract][Full Text] [Related]
12. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
13. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden.
Bentivenga GM; Mammana A; Baiardi S; Rossi M; Ticca A; Magliocchetti F; Mastrangelo A; Poleggi A; Ladogana A; Capellari S; Parchi P
Acta Neuropathol; 2024 Jan; 147(1):18. PubMed ID: 38240849
[TBL] [Abstract][Full Text] [Related]
14. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
Uemura MT; Robinson JL; Cousins KAQ; Tropea TF; Kargilis DC; McBride JD; Suh E; Xie SX; Xu Y; Porta S; Uemura N; Van Deerlin VM; Wolk DA; Irwin DJ; Brunden KR; Lee VM; Lee EB; Trojanowski JQ
Acta Neuropathol; 2022 Jan; 143(1):15-31. PubMed ID: 34854996
[TBL] [Abstract][Full Text] [Related]
15. Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.
Walker DG; Lue LF; Adler CH; Shill HA; Caviness JN; Sabbagh MN; Akiyama H; Serrano GE; Sue LI; Beach TG;
Exp Neurol; 2013 Feb; 240():190-204. PubMed ID: 23201181
[TBL] [Abstract][Full Text] [Related]
16. Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
Forrest SL; Crockford DR; Sizemova A; McCann H; Shepherd CE; McGeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; McGinley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM
Neurology; 2019 May; 92(21):e2472-e2482. PubMed ID: 31019099
[TBL] [Abstract][Full Text] [Related]
17. Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts.
Walker L; McAleese KE; Johnson M; Khundakar AA; Erskine D; Thomas AJ; McKeith IG; Attems J
J Neural Transm (Vienna); 2017 Jun; 124(6):671-683. PubMed ID: 28265813
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological and genetic characteristics of a post-mortem series of cases with dementia with Lewy bodies clinically suspected of Creutzfeldt-Jakob's disease.
Geut H; Vergouw LJM; Galis Y; Ingrassia A; de Jong FJ; Quadri M; Bonifati V; Lemstra AW; Rozemuller AJM; van de Berg WDJ
Parkinsonism Relat Disord; 2019 Jun; 63():162-168. PubMed ID: 30777654
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.
Aoki N; Murray ME; Ogaki K; Fujioka S; Rutherford NJ; Rademakers R; Ross OA; Dickson DW
Acta Neuropathol; 2015 Jan; 129(1):53-64. PubMed ID: 25367383
[TBL] [Abstract][Full Text] [Related]
20. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
